1. Inicio
  2. Publicaciones
  3. What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.

What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Ruiz-Saurí A

Grupos

Abstract

Candida auris has unprecedently emerged as a multidrug resistant fungal pathogen, considered a serious global threat due to its potential to cause nosocomial outbreaks and deep-seated infections with staggering transmissibility and mortality, that has put health authorities and institutions worldwide in check for more than a decade now. Due to its unique features not observed in other yeasts, it has been categorised as an urgent threat by the Centers for Disease Control and Prevention and other international agencies. Moreover, epidemiological alerts have been released in view of the increase of healthcare-associated C. auris outbreaks in the context of the COVID-19 pandemic. This review summarises the current evidence on C. auris since its first description, from virulence to treatment and outbreak control, and highlights the knowledge gaps and future directions for research efforts.

Datos de la publicación

ISSN/ISSNe:
2076-2607, 2076-2607

Microorganisms  MDPI

Tipo:
Article
Páginas:
-
PubMed:
34683498
Factor de Impacto:
0,862 SCImago ℠
Cuartil:
Q2 SCImago ℠

Citas Recibidas en Web of Science: 47

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Candida auris, antifungal agents, candidaemia, diagnosis, epidemiology, outbreak, pathogenesis, virulence

Compartir